Description
Tirzepatide is a synthetic peptide that acts as a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist, commonly referred to as a GIP and GLP-1 receptor agonist.
It is supplied as a lyophilised (freeze-dried) vial for analytical laboratory research and educational use only.
Each batch is produced to 99%+ purity, with third-party sample testing and full Certificate of Analysis support for mass and purity, helping researchers assess the identity, quality and consistency of the materials supplied.
Reported Areas of Research Interest
Tirzepatide has been extensively investigated for its combined activity at the GIP and GLP-1 receptors and the resulting effects on glucose-dependent insulin secretion, appetite signalling, gastric emptying and metabolic regulation.
Areas of scientific and clinical research include:
- GIP and GLP-1 receptor signalling
- Glucose metabolism and glycaemic control
- Glucose-dependent insulin secretion
- Insulin-sensitivity pathways
- Appetite, satiety and food-intake regulation
- Gastric-emptying mechanisms
- Body-weight and body-composition changes
- Lipid and cardiometabolic-risk markers
- Obesity-related health conditions
Clinical studies have reported improvemen







lily –
This has been life changing for me, i have had no sickness or side effects from this peptide! It has got rid of the food noise, I can’t believe the difference it’s made to my life! I have lost over a stone now, feeling so much healthier and happier in myself.